Dificid FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 27, 2020.
Dificid (fidaxomicin) is a macrolide antibacterial drug indicated for the treatment of Clostridioides difficile -associated diarrhea.
Development Timeline for Dificid
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.